Asian Annals Click here to go to Medistim website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Andrea Campione
Luca Luzzi
Luca Voltolini
Maurizio Di Bisceglie
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campione, A.
Right arrow Articles by Gotti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campione, A.
Right arrow Articles by Gotti, G.
Related Collections
Right arrow Lung - cancer
Asian Cardiovasc Thorac Ann 2004;12:149-153
© 2004 Asia Publishing EXchange Ltd

ORIGINAL CONTRIBUTION

Impact of Size, Histology, and Gender on Stage IA Non-Small Cell Lung Cancer

Andrea Campione, MD, Tommaso Ligabue, MD, Luca Luzzi, MD, Claudia Ghiribelli, MD, Piero Paladini, MD, Luca Voltolini, MD, Maurizio Di Bisceglie, MD, Mario Lonzi, MD, Giuseppe Gotti, MD

Department of Surgery, Thoracic Surgery Unit, University Hospital of Siena, Siena, Italy

For reprint information contact: Andrea Campione, MD Tel: 39 0577 585 731 Fax: 39 0577 586 168 Email: andikampione{at}yahoo.it Department of Surgery, Thoracic Surgery Unit, University Hospital, Viale Bracci 1, 53100 Siena, Italy.

The aim of this study was to assess which prognostic factors could influence survival in surgically treated stage IA non-small cell lung cancer. The records of 224 consecutive patients with pathological stage IA after radical surgery were reviewed retrospectively. Overall 1, 3 and 5-year survival rates were 89%, 76%, and 66%. Nearly half of the deaths were unrelated to the original cancer. There was no difference in survival attributable to preoperative pulmonary function, age at operation, or extent of resection. However, patients with limited resections had a higher rate of local recurrence. Survival was better with a smaller size of tumor (= 2 cm), in the female sex, and in cases of bronchoalveolar adenocarcinoma.




This article has been cited by other articles:


Home page
 ChestHome page
D. Arenberg
Bronchioloalveolar Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 306S - 313S.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by the Asia Publishing EXchange Ltd.